Comments on: bluebird bio Announces Launch in Germany of ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia Who Do Not Have β0/β0 Genotype

Comments on: bluebird bio Announces Launch in Germany of ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia Who Do Not Have β0/β0 Genotype https://www.novumpr.nl/2020/01/13/bluebird-bio-announces-launch-in-germany-of-zynteglo-autologous-cd34-cells-encoding-%ce%b2a-t87q-globin-gene-gene-therapy-for-patients-12-years-and-older-with-transfusion-dependent-%ce%b2/?utm_source=rss&utm_medium=rss&utm_campaign=bluebird-bio-announces-launch-in-germany-of-zynteglo-autologous-cd34-cells-encoding-%25ce%25b2a-t87q-globin-gene-gene-therapy-for-patients-12-years-and-older-with-transfusion-dependent-%25ce%25b2 NovumPR press releases Mon, 13 Jan 2020 10:37:21 +0000 hourly 1 https://wordpress.org/?v=6.8.3